Page last updated: 2024-10-26

doxazosin and Bright Disease

doxazosin has been researched along with Bright Disease in 1 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akın, F1
Kılıçaslan, C1
Solak, ES1
Uzun, M1
Aygün, S1
Arslan, Ş1

Other Studies

1 other study available for doxazosin and Bright Disease

ArticleYear
Posterior reversible encephalopathy syndrome in children: report of three cases.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2014, Volume: 30, Issue:3

    Topics: Adolescent; Anticonvulsants; Antihypertensive Agents; Brain Stem; Cerebral Cortex; Child; Child, Pre

2014